Red blood cell utilization in patients with sickle cell disease: A Canadian single-center experience

Kelsey Uminski1, Iris Perelman2, Johnathan Mack2,3

  • 1Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, Alberta, Canada.

Transfusion
|January 23, 2025
PubMed

Insights

Sickle cell disease patients frequently received O-negative red blood cells, with large volumes used for red cell exchange. This data offers a baseline for improving red blood cell use and stewardship.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Sickle Cell Disease Management

Background:

  • Red blood cell (RBC) utilization in Canadian sickle cell disease (SCD) patients is not well-defined.
  • This study examines RBC use within an SCD cohort at a single Canadian center.

Purpose of the Study:

  • To describe and analyze RBC utilization patterns in adult patients with SCD.
  • To establish a baseline for RBC use to inform future quality improvement initiatives.

Main Methods:

  • Retrospective analysis of adult SCD patients at the Ottawa Hospital (January 2006 - May 2019).
  • Data collected on hospital encounters and RBC transfusions from hospital databases.
  • Follow-up extended to December 2021.

Main Results:

  • 273 patients experienced 23,127 hospital encounters; 165 patients received 22,538 RBC units.
  • 86.5% of RBC units were transfused outpatient; O-negative units comprised 29.1% of transfusions.
  • Red cell exchange (RCE) involved 90.2% of transfused RBC units (20,333 units) across 2702 sessions.

Conclusions:

  • SCD patients at this center frequently received O-negative RBC units.
  • Significant volumes of RBCs were utilized for RCE procedures.
  • Findings provide a baseline for RBC stewardship and optimization efforts in SCD care.
Abstract